Shanghai ZJ Bio-Tech Co (688317.SS) Osake Kurssi

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents, and instruments and equipment. The company is headquartered in Shanghai, Shanghai and currently employs 435 full-time employees. The company went IPO on 2021-01-18. The firm is mainly engaged in the research, development, production and sales of genetic diagnostic reagents and equipment. The firm's main products include nucleic acid detection kits and molecular diagnostic instruments. The firm's products are mainly used in areas such as emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm mainly conducts business within the domestic market.